Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	3.12	29.83	28.93
Graham Fair Price	41.42	1.08	0.76
PEG	-55.83	-0.02	0.05
Price/Book	-1.43	0.29	0.29
Price/Cash Flow	-91.05	-18.52	206.81
Prices/Earnings	50.72	-2.00	-4.06
Price/Sales	-50.72	0.20	0.41
Price/FCF	-91.05	-18.52	206.81
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	0.00	0.22	0.22
Operating Margin	-259.79	-0.03	< 0.005
ROA	-100.00	-0.02	< 0.005
ROE	-0.02	-0.04	-100.00
ROIC	< 0.005	-0.04	-575.45
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	0.11	-0.11	-5.64
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.96	-6.20	545.58
EPS QOQ	0.89	-1.00	11.59
FCF QOQ	1.02	-12.01	1079.62
Revenue QOQ	-0.52	1.00	92.32
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	58.28	29.14	-50.00
Days Sales Outstanding (DSO)	72.98	41.35	-43.35
Inventory Turnover	1.54	3.09	100.00
Debt/Capitalization	0.27	0.29	7.59
Quick Ratio	0.82	0.89	9.03
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	1.20	1.20	< 0.005
Cash	0.33	0.33	< 0.005
Capex	-0.01	-0.03	-100.00
Free Cash Flow	< 0.005	-0.02	1000.90
Revenue	0.85	1.71	100.00
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	1.24	1.24	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	7.49	9.87	31.80
Naive Interpretation	Member

06 - Financial Health · Weak

Rating